Competitive Enzyme ImmunoAssay (ELISA) for the determination of antibodies to Hepatitis Delta Virus or HDV in human plasma and sera with a “two-steps” methodology. The kit is used for the follow-up of patients infected by HDV.

Regulatery Status: CE
Catalog No Size
Product Catalog No: DAB Pack Size: 96 Wells

Pack Size:
Pack Size:
Pack Size:
Pack Size:

Category:
Summary

The Hepatitis Delta Virus or HDV is a RNA defective virus composed of a core presenting the delta-specific antigen, encapsulated by HBsAg, that requires the helper function of HBV to support its replication.

Infection by HDV occurs in the presence of acute or chronic HBV infection. When acute delta and acute HBV simultaneously occur, the illness becomes severe and clinical and biochemical features may be indistinguishable from those of HBV infection alone. In contrast, a patient with chronic HBV infection can support HDV replication indefinitely, usually with a less severe illness appearing as a clinical exacerbation.

The determination of HDV specific serological markers (HDV Ag, HDV Ab, HDV IgM and HDV IgG) represents in these cases an important tool to the clinician for the classification of the etiological agent, for the follow up of infected patients and their treatment.

The detection of HDV total antibodies allows the classification of the illness and the monitoring of the seroconversion event.

Test Principle

Anti-HDV antibodies, if present in the sample, compete with a virus-specific polyclonal IgG, labeled with peroxidase (HRP), for a fixed amount of rec-HDV coated on the microplate.

The test is carried out with a two steps incubation competitive system. First the sample is added to the plate and specific anti HDV antibodies bind to the adsorbed antigen. After washing, an enzyme conjugated polyclonal antibody to HDV is added and binds to the free portion of the antigen coated.

After washing a chromogen/substrate mixture is dispensed. The concentration of the bound enzyme on the solid phase becomes inversely proportional to the amount of anti-HDV antibodies in the sample and its activity is detected by the added chromogen/substrate.

The concentration of HDV-specific antibodies in the sample is determined by means of a cut-off value that allows for the semi quantitative detection of anti-HDV antibodies.

Order Enquiry
References
  1. Engvall E. and Perlmann P.. J.Immunochemistry 8: 871- 874, 1971
  2. Engvall E. and Perlmann P.. J.Immunol.. 109: 129-135, 1971
  3. Chaggar K. Et al.. Journal of Virological Methods. 32: 193- 199, 1991
  4. Lazinski D.W. et al.. Journal of Virol.. 67: 2672-2680, 1993
  5. Govindarajan S. et al.. Microbiol. And Immunol.. 95: 140- 141, 1990
  6. Shattock A.G. et al.. J.Clin.Microbiol.. 29: 1873-1876, 1991
  7. Forbes B.A. et al.. Clin.Microbiol.News.. 13: 52-54, 1991
  8. Bergmann, K. et al. J.Immunol. 143:3714-3721, 1989
  9. Bergmann, K. et al. J.Infect.Dis. 154:702-706, 1986
  10. Buti, M. et al. Hepatology 8:1125-1129, 1988
  11. Rizzetto, M. Hepatology 3729-737, 1983
  12. Rizzetto, M. et al. Proc.Natl.Acad.Sci. USA 77:6124-6128, 1980
  13. Dubois, F. et al. J.Clin.Microbiol. 26:1339-1342, 1988
  14. Wang, K. et al. Nature 323:508-514, 1986
Enquiry